For instance, hyperactivation of STAT3 caused by EGFR inhibitors (STAT3 feedback activation) was shown to mediate resistance in lung cancer [9], colorectal cancer [10] and glioma [11]. This evidence concerns the gene STAT3 and colorectal cancer.